- Any - About STIVARGA mCRC GIST HCC Patient Stories Toggle dropdown Videos filtered by: Proven Efficacy: Phase III CORRECT Data 2024-08-09 Please review the CORRECT data and video before viewing other videos What strategies are available for dose management in STIVARGA patients? 2024-08-14 John L. Marshall, MD Medical OncologistWashington, D.C. Can you describe the mechanism of action for STIVARGA? 2024-08-14 John L. Marshall, MD Medical OncologistWashington, D.C. What strategies are available for dose management in STIVARGA patients? 2024-08-14 Arturo Loaiza-Bonilla, MD, MSEd Enterprise Vice Chair of Medical Oncology,Enterprise Medical DirectorCancer Treatment Centers of America Can you describe the mechanism of action for STIVARGA? 2024-08-14 Arturo Loaiza-Bonilla, MD, MSEd Enterprise Vice Chair of Medical Oncology,Enterprise Medical Director Cancer Treatment Centers of America What strategies are available for dose management in STIVARGA patients? 2024-08-14 Kanwal P.S. Raghav, MBBS, MD Medical Director, Division of Ambulatory Treatment Centers, MD Anderson Cancer Center (MDACC), The University of Texas, MDACC, Houston, TX Can you describe the mechanism of action for STIVARGA? 2024-08-14 Kanwal P.S. Raghav, MBBS, MD Medical Director, Division of Ambulatory Treatment Centers, MD Anderson Cancer Center (MDACC), The University of Texas, MDACC, Houston, TX mCRC mechanism of disease at the cellular level 2024-08-14 This video explores key aspects of tumor function and pathologic processes in the mCRC tumor microenvironment Video Categories (field_video_categories) - Any -About STIVARGAmCRCGISTHCCPatient Stories Videos filtered by:
Proven Efficacy: Phase III CORRECT Data 2024-08-09 Please review the CORRECT data and video before viewing other videos
What strategies are available for dose management in STIVARGA patients? 2024-08-14 John L. Marshall, MD Medical OncologistWashington, D.C.
Can you describe the mechanism of action for STIVARGA? 2024-08-14 John L. Marshall, MD Medical OncologistWashington, D.C.
What strategies are available for dose management in STIVARGA patients? 2024-08-14 Arturo Loaiza-Bonilla, MD, MSEd Enterprise Vice Chair of Medical Oncology,Enterprise Medical DirectorCancer Treatment Centers of America
Can you describe the mechanism of action for STIVARGA? 2024-08-14 Arturo Loaiza-Bonilla, MD, MSEd Enterprise Vice Chair of Medical Oncology,Enterprise Medical Director Cancer Treatment Centers of America
What strategies are available for dose management in STIVARGA patients? 2024-08-14 Kanwal P.S. Raghav, MBBS, MD Medical Director, Division of Ambulatory Treatment Centers, MD Anderson Cancer Center (MDACC), The University of Texas, MDACC, Houston, TX
Can you describe the mechanism of action for STIVARGA? 2024-08-14 Kanwal P.S. Raghav, MBBS, MD Medical Director, Division of Ambulatory Treatment Centers, MD Anderson Cancer Center (MDACC), The University of Texas, MDACC, Houston, TX
mCRC mechanism of disease at the cellular level 2024-08-14 This video explores key aspects of tumor function and pathologic processes in the mCRC tumor microenvironment